The COVID-19 pandemic is thought to have originated from a virus that is carried by bats and emerged in human populations in Wuhan, China in late 2019. The virus spread extensively within China and through international travel. Proactive physical distancing measures - shutting down industrial, small business and air travel sectors, schools and public events – slowed the spread within China and internationally. Countries and other geographic areas in Asia that previously experienced SARS and MERS Coronavirus outbreaks rapidly implemented containment measures to keep transmission at low levels. As countries in Europe and North America became aware of outbreaks, containment measures helped decrease demand on hospital intensive care units. Countries in Africa and Latin America were, at the time of writing, beginning to report outbreaks. Although Sub-Saharan Africa is considered highly vulnerable, there has been extensive work by the Africa Centre for Disease Control and the World Health Organization (WHO) Regional Office to prepare countries with training in diagnostic testing and outbreak control, and to provide diagnostic testing materials as a means of strengthening their preparedness.
Understanding of this newly emerged virus has been rapid because scientific and public health experts freely share information with WHO and each other, despite overarching geopolitical tensions. This was also the case during the 2003 outbreak of SARS and during the effort to eradicate smallpox in the 1970s at the height of Cold War tensions.
The destiny of SARS-CoV-2 is not yet known – will it disappear from human populations and possibly return in the future like pandemic influenza and Ebola, or will it become endemic as did HIV that also emerged from the animal kingdom?
"Understanding of this newly emerged virus has been rapid because scientific and public health experts freely share information with the WHO and each other, despite overarching geopolitical tensions."
What is at stake?
In the 5th and 14th century, Plague epidemics spread internationally and killed approximately 15% of the global population over the course of a few decades. Systematic vaccination campaigns have allowed us to eradicate two diseases that had affected humanity for centuries, Smallpox in humans and Rinderpest in animals, and two more diseases – Guinea Worm and Polio – are close to being eradicated. Progress in medical treatment and public health systems has significantly reduced the prevalence and impact of others, such as Malaria, Typhus and Cholera. However, there remains a serious risk that the emergence of a new infectious disease in humans could cause a major outbreak, with particularly high mortality and rapid spread in our densely populated, urbanized and highly interconnected world.
"New developments in synthetic biology... raise concern among certain scientists that an engineered micro-organism...could be released in the population – whether by malice or accident."
How much do we know?
Catastrophic pandemics – diseases with high lethality that spread globally – are extremely disruptive, but very rare. Outbreaks of lethal diseases that remain locally contained or pandemics with less acute effects on human health are however more common, and can have significant disruptive effects.
Outbreaks occur when a micro-organism – virus, bacteria, parasite, etc. – is able to spread across the population. At times and under certain conditions, such as failure of water or sanitation systems, an outbreak is caused by a micro-organism known to be circulating at low levels in human populations. At others, an outbreak is caused by a micro-organism that has crossed the animal/human species barrier to infect humans, and spreads to new and more densely populated areas. If mutation occurs, virulence can increase or decrease. Mutation can also cause a micro-organism to transmit more easily from human to human.
What are key factors affecting risk levels?
New micro-organisms affecting humans are more likely to arise when environments with high levels of biodiversity are disrupted, and when humans or domesticated animals come into close contact with other animal species that serve as reservoirs for micro-organisms not yet present in human populations. Experts now consider this is likely to be the way that the HIV/AIDS epidemic started.
Infections are easier to contain when they occur among small populations with limited external contacts. Conversely, dense urbanisation and global interconnection strongly increase the risk of an infectious disease spreading internationally.
Access to healthcare and the broad adoption of hygiene practices can have a significant effect in reducing the impact of a pandemic. This is especially true in health facilities where infection prevention and control through handwashing and other preventive measures can prevent transmission from amplifying into an outbreak. The capacity to monitor a disease and deploy very rapid containment early in the process also has a large impact on the final number of deaths.
In February 2003, an elderly woman infected by the SARS virus travelled from Hong Kong to Toronto. SARS is a highly infectious and often fatal pulmonary disease that emerged in the Pearl River Delta, in China. The infected woman died soon afterwards in Toronto, after inadvertently infecting over forty people, resulting in a localized outbreak. One of those persons infected in Canada went on a plane to the Philippines, where another outbreak occurred. Meanwhile, from Hong Kong, the virus had also spread to Singapore, where it likewise caused an outbreak.
The outbreaks that occurred around the world were eventually contained, after infecting over 8,000 people, of whom 774 died, through concerted public health action coordinated by the WHO. Severe social and economic disruption occurred, and a similar scenario with only minor variations – a few more international contacts, a slightly longer incubation period for the virus, or a few more days of delay in deploying strict containment measures, could have a similar or even more serious outcome.
Three main factors determine the potential danger of an outbreak:
- Virulence: the ability of a micro-organism to damage human tissues and cause illness and death.
- Infection risk: the probability that a micro-organism will spread in a population. One key factor is the means of transmission – whether by blood, bodily fluids, direct contact with a lesion such as a skin ulcer, or by aerosol in the air.
- Incubation period: the time between infection and appearance of the first symptom(s). A longer incubation period could result in a micro-organism spreading unwittingly, as in the case of HIV. Conversely, a shorter incubation period, if the infection is highly lethal, is less likely to be transmitted unwittingly, and can cause considerable disruption of social, economic and medical systems in a very short period of time. The disruption caused by a highly lethal infection with a longer incubation period, such as HIV, is of longer term consequence.
Ebola is a highly lethal infection with a short incubation period but a relatively low infection rate, which explains why most Ebola outbreaks to date have been localized. New developments in synthetic biology, however, raise concern among certain scientists that an engineered micro-organism both highly virulent and with a high infection rate could be released in the population – whether by malice or accident – and cause an unprecedented outbreak, possibly leading to the international spread of a highly lethal infectious disease.
Antibiotics and Bacteria
Antibiotics have saved millions of lives and dramatically increased lifespans since they were introduced in the 1940s, allowing us to contain most bacterial infections and diseases. However, more recently, as a result of random mutations, improper use of antibiotics among humans and animals, and the buildup effects of evolution, some strains of bacteria have become resistant to traditional antibiotics. These ‘superbugs’ require alternative medications with more damaging side effects or, in the worst cases, can no longer be treated effectively. Antibiotic-resistant bacteria currently kill an estimated 700,000 people. That number is predicted to reach 10 million by 2050 if efforts are not made to curtail resistance or develop new antibiotics.
"Under the International Health Regulations, countries are required to strengthen core capacities in public health that are deemed necessary for rapid detection of, and response to, a disease outbreak."
Governance of pandemics
The World Health Organisation (WHO), established in 1948 as a specialised agency of the United Nations, is currently the global body in charge of governing the risk of...Read more